close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

Get in touch to discover more

To find out more about the Clinical Drug Testing Biochip, enquire now.


Improved Patient Safety

Quicker and more targeted treatment enhances recovery rates and lowers mortality and morbidity.


Improved Patient Management

Biochip simultaneously screens for multiple substances to rapidly direct clinicians to the next steps and efficiently progress an effective treatment plan.


Rapid Identification of Drug Use

The process requires minimal sample preparation, with results in less than 30 minutes. The Biochip is reliable for drug screening, as it provides semi-quantitative concentrations of substances and metabolites.


Comprehensive Testing

Covering a range of drug classes, including common, prescription, and synthetic drugs, Biochip delivers multi-analyte detection, while eliminating the constraints of batch testing.

The multiplex Clinical Drug Testing Biochip provides clinicians with a semi-quantitative comprehensive drug screen in patients for various medical reasons including but not limited to; those presenting acute overdose symptoms, screening for clinical trial eligibility and recurring prescription management. The preliminary test result can assist clinicians in identifying recent illicit drug use, as part of their clinical management workflow.

humidity_low Sample Type:
Urine, Blood & Oral Fluid

update Time to Result:
Under 30 Minutes

Analytes Detected

  • Acetaminophen
  • Amphetamine
  • Barbiturates
  • Benzodiazepines (Oxazepam)
  • Benzodiazepines (Clonazepam)
  • Benzoylecgonine (BZG) / Cocaine
  • Buprenorphine
  • Adulterant Check
  • Ethyl Glucuronide (EtG)
  • Fentanyl
  • Ketamine
  • MDMA
  • Methadone
  • Methamphetamine
  • Opiate
  • Noroxycodone
  • Phencyclidine (PCP)
  • Pregabalin
  • Salicylates
  • Tricyclic Antidepressants (TCA)
  • THC (Cannabinoids)
  • Tramadol
  • Zolpidem
  • 6-Monoacetylmorphine (6-MAM)

The Evidence MultiSTAT

The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.

Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.

With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.

MultiSTAT Cartridge

The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.

The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.

No other components are required.